Login

Lupin Ltd.

₹2057.1

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Lupin Ltd.

₹2057.1

₹2057.1

-38.5 (-1.84%) - 3 May 2025 04:25 PM

About Company

Lupin Limited is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. It has significant presence in the Cardiovascular, Diabetology, Asthama, Pediatrics, Central Nervous System, Gastro-Intestinal, AntiInfectives and Nonsteroidal Anti Inflammatory Drug therapy segments and is a global leader in the Anti-TB and Cephalosporins segments. The company along with its subsidiaries has manufacturing locations spread across India, USA, Mexico and Brazil with trading and other incidental and related activities extending to the global markets.

Market Cap. ₹93,931 Cr.
52 Week - High/Low ₹2,403/1,493
P/E Ratio 30.60
P/B Ratio 4.56
Enterprise Value ₹94,402 Cr.
ROE % 12.0
RSI Value 52.09
EMA 50 2035.68
EMA 200 1993.33
Net Profit 2,326 Cr.
Net Profit 3year growth 84.81 Cr.
Net Profit 3 year (back) 1,259 Cr.
Debt to Equity 0.0 %
EPS Growth TTM 15.05 %
Current Ratio 2.51 %
100 Day SMA 2,083 Rs.
200 Day SMA 2,091 Rs.
21 Day SMA 2,016 Rs.
50 Day SMA 2,006 Rs.
Book Value 451 Rs.
EV/EBITDA Ratio 21
QoQ EPS Growth 22 %
QoQ Operating Profit Growth 20 %
QoQ Sales Growth 2 %
Sales Latest Quarter 4,060 Cr.
YoY Sales Growth 2 %
Market Cap. ₹93,931 Cr.
52 Week - High/Low ₹2,403/1,493
P/E Ratio 32.71
P/B Ratio 6.57
Enterprise Value ₹93,532 Cr.
ROE % 14.61
RSI Value 52.09
EMA 50 2035.68
EMA 200 1993.33
Net Profit 1,914 Cr.
Net Profit 3year growth 14.74 Cr.
Net Profit 3 year (back) 1,217 Cr.
Debt to Equity 0.19 %
EPS Growth TTM 59.86 %
Current Ratio 1.58 %
100 Day SMA 2,083 Rs.
200 Day SMA 2,091 Rs.
21 Day SMA 2,016 Rs.
50 Day SMA 2,006 Rs.
Book Value 313 Rs.
EV/EBITDA Ratio 18
QoQ EPS Growth 0 %
QoQ Operating Profit Growth 1 %
QoQ Sales Growth 2 %
Sales Latest Quarter 5,619 Cr.
YoY Sales Growth 11 %
Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.